CH-REP - Regulatory Affairs - QbD Group (2)

Swiss Authorized Representative (CH-REP)

Are you looking for a Swiss Authorized Representative (CH-REP) for your medical devices and/or IVDs?

Qarad Suisse S.A. – part of the QbD Group – is an independent partner that can act as your Swiss Authorized Representative (CH-REP)

What is a Swiss Authorized Representative?

KEY TO PLACING YOUR DEVICE ON THE SWISS MARKET

Switzerland is not a member of the European Union. Their economic and trade relations with the EU are primarily governed through a series of bilateral agreements, such as the Mutual Recognition Agreement (MRA) which includes the former legislation on medical devices (Medical Device Directive 93/42/EEC and Active Implantable Medical Devices Directive 90/385/EEC), and in vitro diagnostics (In Vitro Diagnostic Directive 98/79/EC).

Within these agreements, Switzerland agreed to adopt certain aspects of EU legislation in exchange for access to part of the EU single market.

When the Medical Device Regulation 2017/745 (MDR) came into force on 26 May 2021, the MRA was not renewed to include the new MDR.

Although Switzerland had updated its Medical Device Ordinance to transpose the MDR into Swiss law (MedDO), the absence of an updated MRA, or any other agreement covering the MDR, resulted in Switzerland becoming a “third country” as of the date of application of the MDR. The same has happened on 26 May, 2022 when the In Vitro Diagnostic medical devices Regulation 2017/746 (IVDR) came into force.

Therefore, medical device and IVD manufacturers without a registered office in Switzerland must appoint a local Swiss Authorized Representative (CH-REP). The Swiss Authorized Representative is responsible for the formal and safety aspects of placing the device on the market in Switzerland.

How can we support you?

OVER 20 YEARS OF EXPERIENCE IN MD & IVD

Qarad Suisse S.A. – part of the QbD Group – builds on expertise as a European Authorized Representative and UK Responsible Person, as well as the regulatory and technical competence of the team.

We can act as an independent CH-REP and keep your regulatory interests separate from your supply chain.

What we offer

Independent representation:
- We act as an independent CH-REP to maintain a clear separation between your regulatory and supply chain interests.
- Avoid potential conflicts of interest associated with appointing a Swiss importer.
Comprehensive support:
- Expertise in Swiss regulations and guidance tailored to your needs.
- Assistance in managing regulatory actions taken against your company.
- Direct communication with Swissmedic on your behalf.

Why partner with QbD Group?

Proven competence:
- Decades of experience in regulatory compliance.
- Strong technical-scientific skills combined with effective communication capabilities.
Alignment with European standards:
- The CH-REP concept mirrors the European MDR/IVDR framework, and Qarad’s expertise ensures a smooth transition.
A trusted partner for Swiss market access:
- Over 100 companies have trusted us for regulatory representation in Europe.
- Our proven methods guarantee easy and efficient access to the Swiss market.

CH-REP - Regulatory Affairs - QbD Group (1)

According to the MDR, I have older devices for which I have a valid certificate from a notified body. Do I need to designate a CH-REP for these devices as well to access the Swiss market?

All other foreign manufacturers must designate a Swiss Authorized Representative effective May 26, 2021. These provisions apply to both MDD/AIMDD and MDR devices.

Should the CH-REP be added to the device labelling?

Yes, the CH-REP data must be added to the device. Depending on the class of the medical device, the CH-REP details must be included on the label and/or in the instructions for use or in a document accompanying the device. Deadlines for adding the CH-REP details also depend on the class of the device.

Related content

Case study

A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader

QbD Group streamlines linguistic reviews for a leading pharma client, ensuring compliance and accuracy across 25 EU/EEA languages while meeting stringent regulatory deadlines.

Whitepaper

Medical Device Regulation (MDR) Checklist

Implement the Medical Device Regulation (MDR) with ease. Download our checklist of mandatory documents for MDR compliance.

Whitepaper

Regulatory Affairs for Pharma and Biotech

In this flyer, you will learn more about the regulatory services QbD Group provides for the pharmaceutical and biotechnology industries.

Whitepaper

Clinical Evaluation for Medical Devices under MDR

This whitepaper will guide you through crucial regulatory documents pertaining to the clinical evaluation process of your medical device. Download now!

Whitepaper

IVDR extension: what does this mean for you?

In this whitepaper, you will learn the impact of the IVDR transition extension and receive tips and strategies to navigate these regulatory changes.

Webinar

Drug-Device Combination Products and Article 117

Explore the regulatory complexities of Drug-Device Combination Products. Learn about Article 117 requirements, Notified Body Opinions, and more.

Whitepaper

Mobile health on the rise: exploring the regulatory landscape for reimbursement

This whitepaper will help you navigate the maze of the DTx regulatory environment, highlighting several important countries and regulations.

Whitepaper

Clinical investigations under MDR: key insights and practical experiences

This whitepaper covers clinical investigation authorization under MDR, the EU Legal Representative's role, and the MDR's impact on study conduct and post-market surveillance.

Case study

CE Mark Renewal for bioXtra Products: A Success Story

Discover how Lifestream Pharma successfully renewed the CE mark for their BioXtra Dry Mouth products under the EU MDR. Learn about the challenges faced, the approach taken for compliance, and the results achieved.

Webinar

Technical Documentation Essentials for Medical Device Software

Gain practical insights on crafting MDR-compliant technical documentation for Medical Device Software.

Webinar

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Watch our webinar on demand and learn about regulatory obstacles, MDR, AI Act, and best practices for medical device software development and market entry.

Webinar

Mastering Clinical Performance Studies under IVDR

In the evolving regulatory landscape of IVDs, demonstrating clinical performance is more crucial and challenging than ever. Discover more in this webinar on demand.

Whitepaper

Clinical evidence for In Vitro Diagnostics under IVDR

In this whitepaper, we will guide you through the documents required for the demonstration of clinical evidence under the IVDR. Download now.

Webinar

Post-Market Surveillance Requirements for Medical Devices and IVDs

Learn about post-market surveillance requirements under MDR and IVDR regulations. Gain insights from industry experts in this on-demand webinar.

Whitepaper

The key role of Regulatory Affairs in the pharmaceutical industry: from drug development to commercialization

Discover the key role of Regulatory Affairs in pharma and how Regulatory Affairs teams support product lifecycle management in this whitepaper. Download now.

Webinar

3D Printing in the Healthcare World

Explore the challenges and opportunities of 3D printing in healthcare, featuring expert insights on regulations, pitfalls, and efficiency.

Webinar

IVDR Extension Explained: Tips & Strategies

Gain valuable insights on the IVDR extension and its impact on IVD manufacturers with our webinar on demand.

Whitepaper

Innovations in ATMP: state of the industry in 2024

This whitepaper explores the innovations in ATMP and solutions in detail, with a focus on the current landscape as of April 2024. Download now.

Case study

The journey toward IVDR compliance for the LVOne device

QbD Group helped Upfront Diagnostics gain entry into the MD/IVD industry by supporting them on their path to ISO 13485 certification.

Case study

Ensuring a smooth MDR transition for Oystershell's medical devices

The landscape of medical device regulations is constantly evolving, making it a challenge for companies to keep up. Our collaboration with Oystershell, which began in July 2023, highlights our expertise in transforming complex challenges into success stories, all with a touch of QbD Clinical magic.

Case study

Successful clinical evaluation supports rapid CE marking of Minze Health's Uroflowmeter

QbD Clinical assisted Minze Health, a urology-focused medical devices company, in obtaining CE marking under MDR through clinical evaluation.

Webinar

The Medical Device CE Certification Pathway Explained: From Classification to Conformity Assessment by the Notified Body

Learn about the Medical Device CE Certification Pathway, from classification to conformity assessment by a Notified Body. Join our webinar on demand.

Case study

Helping Relu to comply with changing regulations

QbD Group supported software company Relu with their expertise to comply with changing regulations.

Case study

Quickly bringing a new COVID-19 medical device to market

Obtaining the required government certifications for a medical device is always a challenge. Especially when the COVID clock is ticking.

Discover all

Get in touch

Your success, our priority.

Simplify your entry into Switzerland’s regulated market while safeguarding your regulatory interests.

Swiss Authorized Representative (CH-REP)

What is a Swiss Authorized Representative?

How can we support you?

Why partner with QbD Group?

According to the MDR, I have older devices for which I have a valid certificate from a notified body. Do I need to designate a CH-REP for these devices as well to access the Swiss market?

Should the CH-REP be added to the device labelling?

Related content

A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader​

Medical Device Regulation (MDR) Checklist

Regulatory Affairs for Pharma and Biotech

Clinical Evaluation for Medical Devices under MDR

IVDR extension: what does this mean for you?

Drug-Device Combination Products and Article 117

Mobile health on the rise: exploring the regulatory landscape for reimbursement

Clinical investigations under MDR: key insights and practical experiences

CE Mark Renewal for bioXtra Products: A Success Story

Technical Documentation Essentials for Medical Device Software

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Mastering Clinical Performance Studies under IVDR

Clinical evidence for In Vitro Diagnostics under IVDR

Post-Market Surveillance Requirements for Medical Devices and IVDs

The key role of Regulatory Affairs in the pharmaceutical industry: from drug development to commercialization

3D Printing in the Healthcare World

IVDR Extension Explained: Tips & Strategies

Innovations in ATMP: state of the industry in 2024

The journey toward IVDR compliance for the LVOne device

Ensuring a smooth MDR transition for Oystershell's medical devices

Successful clinical evaluation supports rapid CE marking of Minze Health's Uroflowmeter

The Medical Device CE Certification Pathway Explained: From Classification to Conformity Assessment by the Notified Body

Helping Relu to comply with changing regulations

Quickly bringing a new COVID-19 medical device to market

Get in touch

A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader